Indian pharmaceuticals sector likely to log revenue growth of 8-10% in FY25: CRISIL
CRISIL Ratings in its latest report has said that the Indian pharmaceuticals sector is likely to log a revenue growth of 8-10% this fiscal (FY25), after around 10% growth last year, supported by healthy exports to regulated markets, recovery in exports to semi-regulated markets and steady domestic demand. The resultant improvement in operating leverage along … Read more